H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Price:
0.325
HKD
Market Closed
Market Cap:
HK$167.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Huakang Biomedical Holdings Co Ltd
HKEX:8622
|
HK |
|
Yijiahe Technology Co Ltd
SSE:603666
|
CN |
|
CGI Inc
NYSE:GIB
|
CA |
|
Alfa Laval AB
STO:ALFA
|
SE |
Income Statement
Earnings Waterfall
Huakang Biomedical Holdings Co Ltd
Huakang Biomedical Holdings Co Ltd
Income Statement
Huakang Biomedical Holdings Co Ltd
Huakang Biomedical Holdings Co Ltd
Currency: CNY
| Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
27
N/A
|
26
-3%
|
25
-2%
|
22
-12%
|
21
-6%
|
21
+1%
|
22
+4%
|
25
+13%
|
27
+9%
|
26
-2%
|
26
-1%
|
27
+4%
|
26
-5%
|
26
+2%
|
25
-4%
|
25
-1%
|
25
-1%
|
24
-3%
|
25
+1%
|
25
+2%
|
25
+1%
|
26
+2%
|
|
| Gross Profit | |||||||||||||||||||||||
| Cost of Revenue |
(7)
|
(7)
|
(8)
|
(7)
|
(6)
|
(7)
|
(7)
|
(8)
|
(10)
|
(10)
|
(10)
|
(10)
|
(9)
|
(9)
|
(8)
|
(8)
|
(8)
|
(9)
|
(9)
|
(9)
|
(8)
|
(8)
|
|
| Gross Profit |
20
N/A
|
19
-6%
|
18
-5%
|
16
-12%
|
15
-7%
|
15
0%
|
15
+1%
|
17
+13%
|
17
+3%
|
17
-3%
|
16
-1%
|
17
+2%
|
17
-2%
|
17
+5%
|
17
-2%
|
17
+0%
|
17
-1%
|
16
-7%
|
16
+2%
|
16
+3%
|
17
+4%
|
17
+3%
|
|
| Operating Income | |||||||||||||||||||||||
| Operating Expenses |
(16)
|
(17)
|
(18)
|
(19)
|
(22)
|
(22)
|
(23)
|
(25)
|
(23)
|
(23)
|
(20)
|
(20)
|
(20)
|
(20)
|
(21)
|
(21)
|
(21)
|
(21)
|
(22)
|
(23)
|
(22)
|
(23)
|
|
| Selling, General & Administrative |
(14)
|
(16)
|
(16)
|
(18)
|
(20)
|
(21)
|
(21)
|
(21)
|
(19)
|
(18)
|
(18)
|
(18)
|
(18)
|
(18)
|
(19)
|
(19)
|
(19)
|
(19)
|
(20)
|
(20)
|
(19)
|
(20)
|
|
| Research & Development |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
(3)
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
4
N/A
|
2
-61%
|
0
-97%
|
(4)
N/A
|
(7)
-89%
|
(8)
-11%
|
(8)
+1%
|
(9)
-9%
|
(6)
+30%
|
(6)
-4%
|
(4)
+40%
|
(3)
+16%
|
(3)
-4%
|
(3)
+4%
|
(4)
-35%
|
(4)
+3%
|
(5)
-16%
|
(6)
-23%
|
(6)
-10%
|
(7)
-2%
|
(5)
+26%
|
(5)
-5%
|
|
| Pre-Tax Income | |||||||||||||||||||||||
| Interest Income Expense |
(0)
|
0
|
1
|
2
|
1
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
0
|
|
| Non-Reccuring Items |
(5)
|
(4)
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(2)
-58%
|
1
N/A
|
(2)
N/A
|
(6)
-187%
|
(8)
-36%
|
(11)
-37%
|
(10)
+14%
|
(7)
+26%
|
(7)
+2%
|
(4)
+45%
|
(3)
+13%
|
(3)
+19%
|
(2)
+28%
|
(3)
-51%
|
(3)
+5%
|
(4)
-27%
|
(5)
-48%
|
(6)
-8%
|
(6)
-7%
|
(4)
+33%
|
(5)
-14%
|
|
| Net Income | |||||||||||||||||||||||
| Tax Provision |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(2)
|
(3)
|
(0)
|
(3)
|
(7)
|
(9)
|
(12)
|
(10)
|
(8)
|
(7)
|
(4)
|
(4)
|
(3)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(6)
|
(6)
|
(4)
|
(5)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(2)
N/A
|
(3)
-19%
|
(0)
+89%
|
(3)
-917%
|
(7)
-129%
|
(9)
-31%
|
(12)
-34%
|
(10)
+13%
|
(8)
+24%
|
(7)
+4%
|
(4)
+43%
|
(4)
+11%
|
(3)
+17%
|
(2)
+22%
|
(3)
-26%
|
(3)
+5%
|
(4)
-23%
|
(5)
-40%
|
(6)
-15%
|
(6)
-6%
|
(4)
+32%
|
(5)
-14%
|
|
| EPS (Diluted) |
-0.01
N/A
|
-0.01
N/A
|
0
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.02
N/A
|
-0.03
-50%
|
-0.03
N/A
|
-0.02
+33%
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
